RPS6 and neoplasm: When activated by sCPE, phosphorylated RPS6 contributed to decrease-, and when pharmacologically inhibited, dephosphorylated RPS6 resulted in an increase of GTP-bound Rac1, therefore affecting tumor cell motility.